Results 171 to 180 of about 60,784 (262)

Data from AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer

, 2023
D. Mark Hickinson, Teresa Klinowska, Georgina Speake, John Vincent, Cath Trigwell, Judith Anderton, Sarah R. Beck, Gayle Marshall, Sara Davenport, Rowena Callis, E. N. Clare Mills, Konstantina Grosios, Paul Smith, Bernard Barlaam, Robert W. Wilkinson, Donald Ogilvie   +15 more
openalex   +1 more source

Surface plasmon resonance microscopy reveals N-glycosylation driven modulation of affinity and avidity of ErbB receptors in whole single pancreatic cancer cells. [PDF]

Glycobiology
Aguilar Díaz de León JS, Thirumurthy M, Ly N.   +2 more
europepmc   +1 more source

Genomic alterations of ERBB receptors in cancer: clinical implications. [PDF]

Oncotarget, 2017
Mishra R, Hanker AB, Garrett JT.
europepmc   +1 more source

EP473 ErbB receptors profiling in selected patients with type II endometrial cancer

, 2019
Georgios Michail, P Panas, F Markatos, Ioanna Styliara, Dimitra Koumoundourou, P. Ravazoula, Georgios Adonakis, Androutsopoulos Georgios   +7 more
openalex   +1 more source

p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor [PDF]

, 1992
DN Poller, C. E. Hutchings, M Galea, JA Bell, R. Nicholson, CW Elston, RW Blamey, Ian O. Ellis   +7 more
openalex   +1 more source

Data from Simultaneous Suppression of Epidermal Growth Factor Receptor and c-erbB-2 Reverses Aneuploidy and Malignant Phenotype of a Human Ovarian Carcinoma Cell Line

, 2023
Svetlana Pack, Özgül M. Alper, Kurt Stromberg, Meena Augustus, Metin Özdemirli, Anne M. Miermont, Greg Klus, Marek Rusin, Rebecca Slack, Neville F. Hacker, Thomas Ried, Zoltán Szállási, Özge Alper   +12 more
openalex   +1 more source

In vitro synergistic effect of AXL, FAK and ErbB receptors inhibitors for head and neck cancer. [PDF]

Biol Direct
Lucarini V, Angiolini V, Nardozi D, Benvenuto M, Focaccetti C, Mancini P, Splendiani E, Autilio TM, Cortese C, Bei R, Nicolai G, Palumbo C, Ferretti E, Cifaldi L, Bei R, Masuelli L.   +15 more
europepmc   +1 more source

Variation of hormonal receptor, pS2, c-erbB-2 and GSTπ contents in breast carcinomas under tamoxifen: a study of 74 cases [PDF]

, 1996
Isabelle Soubeyran, Nathalie Quénel, L. Mauriac, M. Durand, F. Bonichon, Coindre Jm   +5 more
openalex   +1 more source

Natural Products as Chemopreventive Agents by Potential Inhibition of the Kinase Domain in ErbB Receptors. [PDF]

Molecules, 2017
Olivero-Acosta M, Maldonado-Rojas W, Olivero-Verbel J.   +2 more
europepmc   +1 more source

A phase II study of afatinib, an irreversible ErbB family blocker, added to letrozole in patients with estrogen receptor-positive hormone-refractory metastatic breast cancer progressing on letrozole [PDF]

, 2016
K. Gunzer, Florence Joly, Jean-­Marc Ferrero, Joseph Gligorov, H. de Mont-Serrat, Martina Uttenreuther‐Fischer, Katy Pelling, Sven Wind, Guilhem Bousquet, Jean-Louis Misset   +9 more
openalex   +1 more source